Abstract
Chemokine receptors belong to the class A of G protein-coupled receptors (GPCRs) and are implicated in a wide variety of physiologic functions, mostly related to the homeostasis of the immune system. Chemokine receptors are also involved in multiple pathologic processes, including immune and autoimmune diseases, as well as cancer. Hence, several members of this GPCR subfamily are considered to be very relevant therapeutic targets. Since drug discovery efforts can be significantly reinforced by the availability of crystal structures, substantial efforts in the area of chemokine receptor structural biology could dramatically increase the outcome of drug discovery campaigns. This short review summarizes the available data on chemokine receptor crystal structures, discusses the numerous applications from chemokine receptor structures that can enhance the daily work of molecular pharmacologists, and describes the challenges and pitfalls to consider when relying on crystal structures for further research applications. SIGNIFICANCE STATEMENT: This short review summarizes the available data on chemokine receptor crystal structures, discusses the numerous applications from chemokine receptor structures that can enhance the daily work of molecular pharmacologists, and describes the challenges and pitfalls to consider when relying on crystal structures for further research applications.
Original language | English |
---|---|
Pages (from-to) | 765-777 |
Number of pages | 13 |
Journal | Molecular pharmacology |
Volume | 96 |
Issue number | 6 |
DOIs | |
Publication status | Published - 1 Dec 2019 |
Funding
This work was supported by the European Union’s Horizon 2020 Marie Curie Innovative Training Network [Grant 641833 (ONCORNET)] and Eurostars [Grant 12132 (PROTEUS)] programs. https://doi.org/10.1124/mol.119.117168. s This article has supplemental material available at molpharm. aspetjournals.org.
Funders | Funder number |
---|---|
Horizon 2020 Framework Programme | 641833 |
Eurostars | 12132 |